Johnson & Johnson is preparing a potential sale of its orthopedics unit, in a deal that could top $20 billion, with the company eyeing private equity firms as the most likely buyers, a source familiar with the matter has told Reuters.The company did not immediately respond to a Reuters request for comment.J&J last year said it had planned to separate its orthopedics unit, known as DePuy Synthes, into a standalone company within the next 18 to 24 months, marking its second major spinoff in two years as it sh ...

Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has ‌been planning to separate, with big buyout firms already ‌circling, Bloomberg News reported on Thursday, citing people familiar with the matter. The ​business, known as DePuy Synthes, could be valued at more than $20 billion in a sale, according to Bloomberg. The company did not immediately respond to a Reuters request for comment. J&J last year ‌said it had planned ⁠to separate its orthopedics busi ...